Chung-Mei Ling is a notable inventor based in Antioch, IL (US). He has made significant contributions to the field of immunoassays, particularly in the detection of various antigens. With a total of 5 patents to his name, his work has had a considerable impact on clinical diagnostics.

Latest Patents

One of his latest patents is an immunoassay for Neisseria gonorrhoeae antigens. This invention relates to a solid phase immunoassay designed for the detection of Neisseria gonorrhoeae antigens in clinical specimens. The antigens are coated or adsorbed on a solid phase, enhancing the accuracy of the test. Another significant patent involves reagents and methods utilizing labeled Fab bound to antigens. This invention improves the method for immunochemically assaying a member of an antigen-antibody binding pair in serum or plasma. It employs labeled antigen with multiple antigenic binding sites as the indicating reagent, which is particularly useful in hepatitis detection.

Career Highlights

Chung-Mei Ling is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to develop innovative solutions that address critical health issues.

Collaborations

Chung-Mei Ling has collaborated with notable colleagues, including Richard H Decker and Dinah Abram. Their combined expertise has contributed to the advancement of immunoassay technologies.

Conclusion

Chung-Mei Ling's contributions to the field of immunoassays demonstrate his commitment to improving clinical diagnostics. His innovative patents and collaborations highlight the importance of teamwork in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com